Simulations Plus Price to Book Ratio 2010-2025 | SLP
Historical price to book ratio values for Simulations Plus (SLP) over the last 10 years. The current price to book ratio for Simulations Plus as of May 08, 2025 is 3.07.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Simulations Plus Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
| 2025-05-08 |
30.25 |
|
3.21 |
| 2025-02-28 |
28.98 |
$9.43 |
3.07 |
| 2024-11-30 |
31.77 |
$9.20 |
3.45 |
| 2024-08-31 |
36.25 |
$9.10 |
3.98 |
| 2024-05-31 |
48.17 |
$9.04 |
5.33 |
| 2024-02-29 |
41.38 |
$8.86 |
4.67 |
| 2023-11-30 |
39.03 |
$8.63 |
4.52 |
| 2023-08-31 |
44.22 |
$8.53 |
5.18 |
| 2023-05-31 |
43.87 |
$8.50 |
5.16 |
| 2023-02-28 |
37.71 |
$8.26 |
4.57 |
| 2022-11-30 |
40.18 |
$8.87 |
4.53 |
| 2022-08-31 |
59.35 |
$8.80 |
6.75 |
| 2022-05-31 |
46.88 |
$8.77 |
5.34 |
| 2022-02-28 |
38.84 |
$8.55 |
4.54 |
| 2021-11-30 |
46.25 |
$8.35 |
5.54 |
| 2021-08-31 |
43.55 |
$8.23 |
5.29 |
| 2021-05-31 |
51.82 |
$8.22 |
6.30 |
| 2021-02-28 |
70.35 |
$8.05 |
8.74 |
| 2020-11-30 |
54.86 |
$7.92 |
6.93 |
| 2020-08-31 |
58.35 |
$7.83 |
7.45 |
| 2020-05-31 |
49.58 |
$2.62 |
18.93 |
| 2020-02-29 |
31.81 |
$2.32 |
13.74 |
| 2019-11-30 |
32.59 |
$2.22 |
14.66 |
| 2019-08-31 |
35.15 |
$2.14 |
16.41 |
| 2019-05-31 |
24.37 |
$2.05 |
11.87 |
| 2019-02-28 |
19.88 |
$1.93 |
10.31 |
| 2018-11-30 |
19.15 |
$1.85 |
10.34 |
| 2018-08-31 |
20.09 |
$1.83 |
10.96 |
| 2018-05-31 |
18.44 |
$1.79 |
10.29 |
| 2018-02-28 |
14.88 |
$1.70 |
8.74 |
| 2017-11-30 |
14.83 |
$1.54 |
9.61 |
| 2017-08-31 |
13.77 |
$1.49 |
9.22 |
| 2017-05-31 |
11.55 |
$1.46 |
7.90 |
| 2017-02-28 |
9.10 |
$1.39 |
6.57 |
| 2016-11-30 |
8.87 |
$1.36 |
6.54 |
| 2016-08-31 |
8.04 |
$1.32 |
6.09 |
| 2016-05-31 |
7.09 |
$1.26 |
5.61 |
| 2016-02-29 |
8.82 |
$1.19 |
7.39 |
| 2015-11-30 |
8.20 |
$1.17 |
6.99 |
| 2015-08-31 |
6.16 |
$1.15 |
5.34 |
| 2015-05-31 |
5.34 |
$1.17 |
4.55 |
| 2015-02-28 |
5.71 |
$1.11 |
5.15 |
| 2014-11-30 |
5.67 |
$1.10 |
5.17 |
| 2014-08-31 |
5.94 |
$0.94 |
6.29 |
| 2014-05-31 |
5.30 |
$0.98 |
5.42 |
| 2014-02-28 |
4.96 |
$0.89 |
5.55 |
| 2013-11-30 |
4.33 |
$0.89 |
4.85 |
| 2013-08-31 |
4.09 |
$0.89 |
4.61 |
| 2013-05-31 |
3.73 |
$0.90 |
4.14 |
| 2013-02-28 |
3.39 |
$0.87 |
3.91 |
| 2012-11-30 |
3.72 |
$0.94 |
3.96 |
| 2012-08-31 |
3.61 |
$0.95 |
3.79 |
| 2012-05-31 |
3.16 |
$0.98 |
3.23 |
| 2012-02-29 |
3.17 |
$0.97 |
3.26 |
| 2011-11-30 |
2.40 |
$0.97 |
2.48 |
| 2011-08-31 |
2.52 |
$0.90 |
2.79 |
| 2011-05-31 |
2.26 |
|
0.00 |
| 2011-02-28 |
2.57 |
|
0.00 |
| 2010-11-30 |
2.32 |
|
0.00 |
| 2010-08-31 |
1.92 |
|
0.00 |
| 2010-05-31 |
1.88 |
|
0.00 |
| 2010-02-28 |
1.30 |
|
0.00 |
| 2009-11-30 |
1.10 |
|
0.00 |
| 2009-08-31 |
1.40 |
|
0.00 |
| 2009-05-31 |
0.87 |
|
0.00 |
| 2009-02-28 |
0.72 |
|
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Computer Software |
$0.583B |
$0.070B |
|
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|
